Philippe M. Joly

Groupement Hospitalier Est, UF Centre De Biologie Est
Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 142 publications

Dalcetrapib decreases red blood cell sickling propensity in sickle cell disease.

Dalcetrapib decreases red blood cell sickling propensity in sickle cell disease.

Journal: Clinical hemorheology and microcirculation

Published: August 12, 2026

Is it time to implement a hemorheology passport in sickle cell disease?

Is it time to implement a hemorheology passport in sickle cell disease?

Journal: Blood cells, molecules & diseases

Published: June 05, 2026

Albumin priming enables safe and effective red blood cell exchange in low-weight children with sickle cell disease.

Albumin priming enables safe and effective red blood cell exchange in low-weight children with sickle cell disease.

Journal: Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Published: May 05, 2026

Should we longitudinally monitor blood viscosity in patients with sickle cell anemia?

Should we longitudinally monitor blood viscosity in patients with sickle cell anemia?

Journal: Blood cells, molecules & diseases

Published: April 22, 2026

Red blood cell Piezo1 Activation Drives Faster Coagulation and Structural Alterations in Blood Clots through Red Blood Cell Deformability Impairment.

Red blood cell Piezo1 Activation Drives Faster Coagulation and Structural Alterations in Blood Clots through Red Blood Cell Deformability Impairment.

Journal: Seminars in thrombosis and hemostasis

Published: April 01, 2026

Red Blood Cell Piezo1 Activation Drives Faster Coagulation and Structural Alterations in Blood Clots through Red Blood Cell Deformability Impairment.

Red Blood Cell Piezo1 Activation Drives Faster Coagulation and Structural Alterations in Blood Clots through Red Blood Cell Deformability Impairment.

Journal: Seminars in thrombosis and hemostasis

Published: April 01, 2026

In vitro effects of voxelotor on red blood cell senescence and rheological behavior in sickle cell anemia.

In vitro effects of voxelotor on red blood cell senescence and rheological behavior in sickle cell anemia.

Journal: Blood cells, molecules & diseases

Published: March 26, 2026

Deep intronic ANK1 variants causing pseudo-exon inclusion in hereditary spherocytosis: Whole-genome sequencing and functional assessment.

Deep intronic ANK1 variants causing pseudo-exon inclusion in hereditary spherocytosis: Whole-genome sequencing and functional assessment.

Journal: British journal of haematology

Published: March 09, 2026

Persisting elevation of total hemoglobin mass after altitude training in elite swimmers: a potential role of prolonged erythrocyte survival.

Persisting elevation of total hemoglobin mass after altitude training in elite swimmers: a potential role of prolonged erythrocyte survival.

Journal: American journal of physiology. Heart and circulatory physiology

Published: August 18, 2025

Differences in oxygen-gradient ektacytometry parameters and blood viscosity between patients with sickle cell anemia and patients with sickle cell-hemoglobin C disorder.

Differences in oxygen-gradient ektacytometry parameters and blood viscosity between patients with sickle cell anemia and patients with sickle cell-hemoglobin C disorder.

Journal: Clinical hemorheology and microcirculation

Published: July 08, 2025

Quantification of the Effect of Saddle Fitting on Rider-Horse Biomechanics Using Inertial Measurement Units.

Quantification of the Effect of Saddle Fitting on Rider-Horse Biomechanics Using Inertial Measurement Units.

Journal: Sensors (Basel, Switzerland)

Published: June 17, 2025

Impact of elevated red blood cell membrane cholesterol in sickle cell anemia patients: Effects of BRN-002, a 2-hydroxypropyl-β-cyclodextrin derivate, on red blood cell lipids, deformability, sickling and hemolysis.

Impact of elevated red blood cell membrane cholesterol in sickle cell anemia patients: Effects of BRN-002, a 2-hydroxypropyl-β-cyclodextrin derivate, on red blood cell lipids, deformability, sickling and hemolysis.

Journal: Blood cells, molecules & diseases

Published: May 22, 2025

Showing 1-12 of 142

Last Updated: 09/26/2026